Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreas transplantation.

D E Sutherland1, S A Gruber

  • 1Department of Surgery, University of Minnesota Hospital and Clinic, Minneapolis.

Critical Care Clinics
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Pancreas transplantation is effective for severe diabetes complications but requires safer anti-rejection drugs for broader use. Current strategies limit its application to patients with serious diabetes issues outweighing transplant risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of tumor necrosis factor alpha and of the soluble tumor necrosis factor receptor on insulin secretion of isolated islets of Langerhans.

Transplantation proceedings·1992
Same author

Neonatal tolerance induction in diabetes-prone BB rats as a model for donor-specific pancreas transplantation during adulthood.

Transplantation proceedings·1992
Same author

Conversion of exocrine secretions from bladder to enteric drainage in recipients of whole pancreaticoduodenal transplants.

Annals of surgery·1992
Same author

Toxic effect of ethylene-oxide-sterilized freeze-dried bone allograft on human gingival fibroblasts.

Journal of biomedical materials research·1992
Same author

Pancreas rejection. Significance of histopathologic findings with implications for classification of rejection.

The American journal of surgical pathology·1992
Same author

Chemical hepatitis associated with occupational exposure to halothane in a research laboratory.

Veterinary and human toxicology·1992
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Area of Science:

  • Transplantation immunology
  • Endocrinology
  • Nephrology

Background:

  • Pancreas transplantation is a potential treatment for type 1 diabetes.
  • Current immunosuppressive therapies for pancreas transplants carry significant side effects.
  • Widespread application is limited by the risks of immunosuppression.

Purpose of the Study:

  • To evaluate the current status and limitations of pancreas transplantation.
  • To identify the criteria for patient selection in pancreas transplantation.
  • To discuss the future directions for improving pancreas transplantation outcomes.

Main Methods:

  • Review of current clinical practice and literature on pancreas transplantation.
  • Analysis of patient selection criteria based on diabetes complications and transplant risks.

Related Experiment Videos

  • Discussion of the balance between diabetes management and immunosuppression side effects.

    • Main Results:

    • Pancreas transplantation is an established procedure for select diabetic patients with severe complications.
    • The benefits of transplantation must outweigh the risks of chronic immunosuppression.
    • Development of safer anti-rejection strategies is crucial for expanding its use.

    Conclusions:

    • Pancreas transplantation is a viable therapeutic option for carefully selected diabetic patients.
    • Further research into novel immunosuppressive agents is needed.
    • Improved anti-rejection protocols will enable broader application of pancreas transplantation.